GENERAL INFORMATION
 
 
 
 
| ISSN: 2429-5396 (e) | www.american-jiras.com |                                                                                      |
|
Web Site Form: v 0.1.05 | JF 22 Cours, Wellington le Clairval, Lillebonne | France  |
 
 
 
ResearchBib, Google Scholar, SIS database, i.f.s.i.j, Scribd, IISJ, Eurasian Scientific Journal Index (ESJI), Indianscience.in, arastirmax, Directory of Research Journals
Indexing, Pak Academic Sesearch, AcademicKeays, CiteSeerX, UDL Library,  CAS Abstracts, J-Gate, WorldCat, Scirus, IET Inspec Direct, and getCited
Indexed by:
| HOME | ABOUT US | ARCHIVE | AIMS AND SCOP | AUTHORS | REVIEW | SUMIBMIT MANUSCRIPT | EDITORIAL BOARED | PUBLICATION FEE |
  | ARTICLES | Am. J. innov. res. appl. sci. Volume 10,  Issue 3, Pages 93-105 (March, 2020)
Revew Article 5
 
|
American Journal of innovative
Research & Applied Sciences 
ISSN  2429-5396 (Online)
OCLC Number: 920041286
| HOME || ABOUT US  || ARCHIVES || AIMS AND SCOP || AUTHORS || REVIEW|| SUBMIT MANUSCRIPT || EDITORIAL BOARD || CONTACT US |
| IMPACT FACTOR AND INDEXING | | PUBLICATION FEE |
| FEBRUARY | VOLUME 10 | N° 3 | 2020 |
| Info-AJIRAS-® Journal ISSN 2429-5396 (Online) / Reference  CIF/15/0289M |
  American Journal of Innovative Research & Applied Sciences
ABSTRACT

Endometrial cancer (EC) is the most frequent gynecologic malignancy and the 4th in females. Most patients (68%) have a locally advanced disease with nodal involvement and non-negligible cases (8%) have metastatic disease with 5-year survival respectively 67 % and 16 %. Curative surgery remains the standard treatment with a good prognosis, however, the risk of relapse increase according to the initial stage. During the last 20 years, therapeutic arsenal of EC, have been enriched by loco-regional radiotherapy, chemotherapy and hormonotherapy, in adjuvant but also in relapsing patients. Nowadays, therapeutic management must arise from a multidisciplinary team guided by clinical, histopathological and biomolecular features.
Key-words: Endometrial, adenocarcinoma, Systemic treatment, Hormonotherapy, Targeted therapy

*Corresponding author Author & Copyright Author © 2020: | Wafaa Kaikani |. All Rights Reserved. All articles published in American Journal of Innovative Research and
Applied Sciences are the property of Atlantic Center Research Sciences, and is protected by copyright laws CC-BY. See: http://creativecommons.org/licenses/by-nc/4.0/
Authors Contact

*Correspondant author and authors Copyright © 2020:

| Wafaa Kaikani *1.2 | Asmaa Naim 1.2 | and | Hamouda Boussen 3 |

Affiliation.

1. Faculté de médecine | Université Mohammed VI des Sciences de la Santé | MAROC |
2. Hôpital Universitaire International Cheikh Khalifa | Maroc |
3. Hôpital A Mami | Ariana | Tunis |

This article is made freely available as part of this journal's Open Access: ID | Wafaa-Ref.4-ajiras070220 |
PLACE DU TRAITEMENT MEDICAL DANS LA PRISE EN CHARGE DES ADENOCARCINOMES
DE L’ENDOMETRE

PLACE OF MEDICAL TREATMENT IN THE MANAGEMENT OF ENDOMETER ADENOCARCINOMAS

        | Wafaa Kaikani *1.2 | Asmaa Naim 1.2 | and | Hamouda Boussen 3 |.  Am. J. innov. res. appl. sci. 2020; 10(3):99-105.

    | PDF FULL TEXT |   | XML FILE | Received | January 07, 2020 | | Accepted | February 27, 2020 |  | Published | March 02, 2020 |